X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (16723) 16723
Publication (1575) 1575
Newsletter (1056) 1056
Newspaper Article (433) 433
Magazine Article (253) 253
Book Review (104) 104
Book Chapter (44) 44
Dissertation (26) 26
Book / eBook (10) 10
Conference Proceeding (8) 8
Reference (8) 8
Trade Publication Article (7) 7
Government Document (5) 5
Paper (4) 4
Web Resource (4) 4
Data Set (3) 3
Report (1) 1
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (12055) 12055
zidovudine (9476) 9476
female (5552) 5552
hiv infections - drug therapy (5052) 5052
zidovudine - therapeutic use (5039) 5039
male (4613) 4613
adult (4138) 4138
aids (3708) 3708
hiv (3674) 3674
infectious diseases (3617) 3617
anti-hiv agents - therapeutic use (3099) 3099
immunology (2626) 2626
pregnancy (2347) 2347
human-immunodeficiency-virus (2259) 2259
pharmacology & pharmacy (2192) 2192
zidovudine - pharmacology (2142) 2142
drug therapy, combination (2099) 2099
index medicus (2007) 2007
virology (1948) 1948
hiv-1 - drug effects (1928) 1928
drug therapy (1921) 1921
acquired immunodeficiency syndrome - drug therapy (1862) 1862
zidovudine - administration & dosage (1820) 1820
middle aged (1819) 1819
hiv infection (1749) 1749
hiv infections - transmission (1643) 1643
animals (1639) 1639
hiv-1 (1515) 1515
infection (1500) 1500
antiretroviral therapy (1480) 1480
medicine, general & internal (1436) 1436
hiv infections - virology (1419) 1419
lamivudine (1403) 1403
viral load (1388) 1388
cd4 lymphocyte count (1377) 1377
infant, newborn (1374) 1374
therapy (1361) 1361
hiv-1 - genetics (1346) 1346
hiv infections - prevention & control (1341) 1341
zidovudine - adverse effects (1300) 1300
research (1295) 1295
infectious disease transmission, vertical - prevention & control (1248) 1248
health aspects (1159) 1159
anti-hiv agents - administration & dosage (1101) 1101
reverse transcriptase inhibitors - therapeutic use (1100) 1100
microbiology (1044) 1044
anti-hiv agents - pharmacology (1035) 1035
antiviral agents (1033) 1033
infant (1031) 1031
hiv infections - immunology (953) 953
lamivudine - therapeutic use (947) 947
azt (937) 937
prevention (926) 926
risk factors (915) 915
time factors (907) 907
human immunodeficiency virus (897) 897
adolescent (880) 880
mutation (872) 872
immunodeficiency-virus type-1 (860) 860
pregnancy complications, infectious - drug therapy (856) 856
treatment outcome (848) 848
anti-hiv agents - adverse effects (839) 839
antiviral agents - therapeutic use (821) 821
child (808) 808
hiv infections - complications (791) 791
aids-related complex (755) 755
nevirapine (746) 746
human immunodeficiency virus--hiv (739) 739
research article (716) 716
highly active antiretroviral therapy (715) 715
reverse transcriptase inhibitors - pharmacology (709) 709
pharmacokinetics (708) 708
reverse-transcriptase (704) 704
viruses (701) 701
biochemistry & molecular biology (699) 699
type-1 (688) 688
rna, viral - blood (682) 682
virus diseases (674) 674
didanosine - therapeutic use (669) 669
evaluation (668) 668
antiretroviral therapy, highly active (664) 664
didanosine (661) 661
transmission (661) 661
placebo-controlled trial (658) 658
zidovudine - pharmacokinetics (656) 656
drugs (655) 655
double-blind (654) 654
mice (654) 654
care and treatment (653) 653
cohort studies (649) 649
antiviral agents - pharmacology (642) 642
protease inhibitors (626) 626
prospective studies (625) 625
hiv infections - epidemiology (621) 621
virus replication - drug effects (621) 621
hiv-1 - isolation & purification (612) 612
drug resistance (597) 597
cell line (595) 595
antiretroviral drugs (592) 592
zidovudine - analogs & derivatives (590) 590
more...
Library Location Library Location
Library Location Library Location
X
Sort by Item Count (A-Z)
Filter by Count
Gerstein Science - Stacks (9) 9
Thomas Fisher Rare Book - Rare Book (4) 4
St. Michael's College (John M. Kelly) - 2nd Floor (2) 2
Collection Dvlpm't (Acquisitions) - Closed Orders (1) 1
May be requested (1) 1
New College (Ivey) - Stacks (1) 1
UTL at Downsview - May be requested (1) 1
UTL at Downsview - Pharmacy (1) 1
University College (Laidlaw) - Stacks (1) 1
UofT at Scarborough - Stacks (1) 1
more...
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (17415) 17415
French (333) 333
Spanish (282) 282
German (206) 206
Russian (60) 60
Japanese (55) 55
Portuguese (50) 50
Italian (39) 39
Chinese (35) 35
Dutch (30) 30
Polish (13) 13
Danish (12) 12
Norwegian (7) 7
Swedish (6) 6
Hungarian (4) 4
Korean (3) 3
Serbian (3) 3
Turkish (3) 3
Czech (2) 2
Finnish (2) 2
Hebrew (2) 2
Lithuanian (1) 1
Slovak (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Medecine et Maladies Infectieuses, ISSN 0399-077X, 06/2017, Volume 47, Issue 4, p. S146
L'epidemie liee au VIH demeure un probleme de sante publique mondial. Une des 4 priorites de l'OMS dans la lutte contre cette epidemie reste la prevention de... 
Zidovudine
Journal Article
Practical Diabetes, ISSN 2047-2897, 03/2015, Volume 32, Issue 2, pp. 76 - 77
Journal Article
Journal of Neurosciences in Rural Practice, ISSN 0976-3147, 07/2011, Volume 2, Issue 2, p. 206
Journal Article
Journal of Molecular and Cellular Cardiology, ISSN 0022-2828, 06/2006, Volume 40, Issue 6, pp. 867 - 868
Journal Article
Revue Francophone des Laboratoires, ISSN 1773-035X, 05/2011, Volume 2011, Issue 432, p. 77
Les ongles peuvent A*tre la cible d'effets indesirables medicamenteux, soit en parallele d'une atteinte cutanee plus diffuse, soit de facon isolee. La... 
Zidovudine
Journal Article
AIDS, ISSN 0269-9370, 02/2017, Volume 31, Issue 4, pp. 501 - 509
Journal Article
The Journal of Infectious Diseases, ISSN 0022-1899, 10/2008, Volume 198, Issue 8, pp. 1113 - 1122
Background. Vicriviroc (VCV) is a CCR5 antagonist with nanomolar activity against human immunodeficiency virus (HIV) replication in vitro and in vivo. We... 
HIV/AIDS | Tropisms | RNA | HIV | Placebos | Viruses | AIDS | Infections | Dosage | HIV 1 | Virology | INFECTIOUS DISEASES | MYOCARDIAL-INFARCTION | MICROBIOLOGY | IMMUNOLOGY | HUMAN-IMMUNODEFICIENCY-VIRUS | PROGNOSTIC VALUE | CCR5 ANTAGONIST | INDIVIDUALS | ANTIRETROVIRAL-DRUG-RESISTANCE | SYNCYTIUM-INDUCING PHENOTYPE | EPIDEMIOLOGY | DISEASE PROGRESSION | Piperazines - administration & dosage | Lamivudine - administration & dosage | Humans | Male | RNA, Viral - blood | Reverse Transcriptase Inhibitors - administration & dosage | Viral Load | Zidovudine - administration & dosage | Anti-HIV Agents - administration & dosage | Lamivudine - adverse effects | Reverse Transcriptase Inhibitors - adverse effects | HIV-1 - physiology | Lamivudine - therapeutic use | Adult | Anti-HIV Agents - therapeutic use | Female | Reverse Transcriptase Inhibitors - therapeutic use | Drug Therapy, Combination | CCR5 Receptor Antagonists | Benzoxazines - administration & dosage | Double-Blind Method | Zidovudine - adverse effects | HIV-1 - drug effects | Pyrimidines - administration & dosage | Anti-HIV Agents - adverse effects | HIV Infections - virology | Benzoxazines - adverse effects | Treatment Outcome | CD4 Lymphocyte Count | Piperazines - therapeutic use | Piperazines - adverse effects | Benzoxazines - therapeutic use | Pyrimidines - therapeutic use | Pyrimidines - adverse effects | HIV Infections - drug therapy | Zidovudine - therapeutic use | Lamivudine | Dosage and administration | HIV (Viruses) | Drug therapy | Zidovudine | Index Medicus | Abridged Index Medicus
Journal Article
The New England Journal of Medicine, ISSN 0028-4793, 06/2012, Volume 366, Issue 25, pp. 2368 - 2379
In this randomized trial involving neonates whose HIV-infected mothers did not receive antenatal antiretroviral therapy (ART), combination ART significantly... 
VIRAL LOAD | ZIDOVUDINE TREATMENT | MEDICINE, GENERAL & INTERNAL | PERINATAL TRANSMISSION | POSTEXPOSURE PROPHYLAXIS | RESISTANCE | RANDOMIZED-TRIAL | HUMAN-IMMUNODEFICIENCY-VIRUS | TO-CHILD TRANSMISSION | MATERNAL-INFANT TRANSMISSION | NEVIRAPINE | HIV-1 | HIV Infections - prevention & control | Humans | Drug Resistance, Viral | Male | Nevirapine - therapeutic use | Postpartum Period | Pregnancy Complications, Infectious | Nevirapine - adverse effects | Lamivudine - adverse effects | Drug Therapy, Combination - adverse effects | Lamivudine - therapeutic use | Female | HIV Infections - mortality | HIV Infections - transmission | Infant, Newborn | Nelfinavir - therapeutic use | Anti-Retroviral Agents - therapeutic use | Zidovudine - adverse effects | Infant Formula | Anti-Retroviral Agents - adverse effects | Kaplan-Meier Estimate | Nelfinavir - adverse effects | Pregnancy | Zidovudine - therapeutic use | Infectious Disease Transmission, Vertical - prevention & control | Drugs | Infants (Newborn) | Dose-response relationship (Biochemistry) | Control | Disease transmission | Product/Service Evaluations | Dosage and administration | Drug therapy | HIV infection | Health aspects | Zidovudine | Neonates | Antiretroviral drugs | Breastfeeding & lactation | Nevirapine | Toxicity | Prophylaxis | Lamivudine | Infants | Birth | Multivariate analysis | Antiretroviral therapy | Postpartum | Human immunodeficiency virus--HIV | Nelfinavir | Birth weight | Drug dosages | Neutropenia | Index Medicus | Abridged Index Medicus
Journal Article
Journal Article
The New England Journal of Medicine, ISSN 0028-4793, 11/2008, Volume 359, Issue 21, pp. 2233 - 2244
Journal Article
04/2014
Background: Herb-drug interaction (HDI) has been regarded as a key factor limiting the clinical application of herbs and drugs. Aims: Potential... 
herb-drug interaction | Baicalein | zidovudine (AZT) | metabolism
Web Resource
Journal of Pharmaceutical Sciences, ISSN 0022-3549, 01/2015, Volume 104, Issue 1, pp. 244 - 256
In this study, we aimed to determine the modulatory effects of warfarin (an extensively used anticoagulant drug) and its metabolites on... 
UGT | zidovudine | bioavailability | drug–drug interactions | pharmacokinetics | warfarin | phase II metabolism | Warfarin | Drug-drug interactions | Bioavailability | Phase II metabolism | Pharmacokinetics | Zidovudine | CHEMISTRY, MEDICINAL | VIVO | GLUCURONIDATION | RATS | MECHANISMS | HUMAN LIVER-MICROSOMES | CHEMISTRY, MULTIDISCIPLINARY | drug-drug interactions | IN-VITRO | INHIBITION | PHARMACOLOGY & PHARMACY | BINDING | 2B7 UGT2B7 | DRUG-METABOLISM | Anti-HIV Agents - pharmacology | Gene Expression Regulation, Enzymologic - drug effects | Zidovudine - metabolism | Liver - enzymology | Humans | Microsomes, Liver - metabolism | Zidovudine - pharmacokinetics | Warfarin - adverse effects | Biological Availability | Male | Isoenzymes - chemistry | Glucuronides - blood | Warfarin - pharmacology | Glucuronosyltransferase - genetics | Drug Interactions | Glucuronides - metabolism | Liver - drug effects | Anticoagulants - chemistry | Isoenzymes - metabolism | Microsomes, Liver - drug effects | Microsomes, Liver - enzymology | Anti-HIV Agents - blood | Anti-HIV Agents - metabolism | Recombinant Proteins - metabolism | Hydroxylation | Isoenzymes - genetics | Liver - metabolism | Zidovudine - pharmacology | Random Allocation | Anticoagulants - adverse effects | Rats, Sprague-Dawley | Warfarin - analogs & derivatives | Animals | Glucuronosyltransferase - chemistry | Glucuronosyltransferase - metabolism | Models, Biological | Anti-HIV Agents - pharmacokinetics | Anticoagulants - pharmacology | Biotransformation - drug effects | Kinetics | Zidovudine - blood | Enzymes | Metabolites | Analysis
Journal Article
Nature Structural & Molecular Biology, ISSN 1545-9993, 10/2010, Volume 17, Issue 10, pp. 1202 - 1209
Journal Article